StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 14 Jul 2026 07:34:45 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Maxim Group Starts Heartbeam Inc. (BEAT) at Buy http://www.streetinsider.com/New+Coverage/Maxim+Group+Starts+Heartbeam+Inc.+%28BEAT%29+at+Buy/26764865.html <p>Maxim Group analyst Anthony Vendetti initiates coverage on Heartbeam Inc. (NASDAQ: BEAT) with a Buy rating and a price target of $2.00.</p><p>For an analyst ratings summary and ratings history on Heartbeam Inc. <a href="http://www.streetinsider.com/rating_history.php?q=BEAT">click here</a>. For more ratings news on Heartbeam Inc. <a href="http://www.streetinsider.com/stock_lookup_news.php?q=BEAT&type=analyst">click here</a>.</p><p>Shares of Heartbeam Inc. closed at $0.58 yesterday.</p> http://www.streetinsider.com/New+Coverage/Maxim+Group+Starts+Heartbeam+Inc.+%28BEAT%29+at+Buy/26764865.html Tue, 14 Jul 2026 07:34:45 -0400 BEAT HeartBeam awarded patent for acoustic and fluid sensing on ECG device http://www.streetinsider.com/Corporate+News/HeartBeam+awarded+patent+for+acoustic+and+fluid+sensing+on+ECG+device/26764684.html <p>HeartBeam, Inc. (NASDAQ: BEAT) has been awarded a new U.S. patent covering acoustic sensing and thoracic impedance measurement capabilities for its credit card-sized, cable-free ECG device, according to a press release from the Santa Clara, California-based medical technology company.</p><p>The patent covers the integration of acoustic sensors into the foldable arms of the HeartBeam device, allowing it to capture sounds produced by heart valves, including the mitral and tricuspid valves. The patent also covers thoracic impedance measurement, which involves injecting a small current through the device's finger electrodes and measuring the resulting voltage across chest electrodes to assess fluid levels in http://www.streetinsider.com/Corporate+News/HeartBeam+awarded+patent+for+acoustic+and+fluid+sensing+on+ECG+device/26764684.html Tue, 14 Jul 2026 07:02:39 -0400 BEAT HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Press+Releases/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html <ul class="bwlistdisc"> <li> <i>Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilities</i> </li> <li> <i>Acoustic sensors enable HeartBeam’s device to function as a “digital stethoscope” to assess heart valve function</i> </li> <li> <i>Thoracic impedance capability opens the door to heart failure monitoring without a surgical procedure</i> </li> <li> <i>HeartBeam now holds 26 issued patents worldwide, reflecting continued investment in building a durable IP moat around its platform</i> </li> </ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54569973&newsitemid=20260714128308&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=2fbcd20e475e73f156fc7408b9193017" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the allowance of a new U.S. patent that significantly expands the capabilities of http://www.streetinsider.com/Business+Wire/HeartBeam+Awarded+New+U.S.+Patent+Expanding+Acoustic+Sensing+and+Fluid+Monitoring+Capabilities+of+Its+Cable-Free+ECG+Device/26764601.html Tue, 14 Jul 2026 07:00:00 -0400 A.13453867 BEAT O.20404981 O.52737737 Form 8-K HeartBeam, Inc. For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HeartBeam%2C+Inc.+++++++++++For%3A+Jun+30/26727995.html si-local-file:///var/storage/secattach/20260702/26727995.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HeartBeam%2C+Inc.+++++++++++For%3A+Jun+30/26727995.html Thu, 02 Jul 2026 16:16:00 -0400 BEAT O.52737737 Form 8-K HeartBeam, Inc. For: Jun 30 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HeartBeam%2C+Inc.+++++++++++For%3A+Jun+30/26727995.html si-local-file:///var/storage/secattach/20260702/26727995.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HeartBeam%2C+Inc.+++++++++++For%3A+Jun+30/26727995.html Thu, 02 Jul 2026 16:16:00 -0400 BEAT O.52737737 HeartBeam finishes heart attack pilot study enrollment early http://www.streetinsider.com/Corporate+News/HeartBeam+finishes+heart+attack+pilot+study+enrollment+early/26709433.html <p>HeartBeam, Inc. (NASDAQ: BEAT) announced it has completed patient enrollment in its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection, ahead of its previously stated third-quarter 2026 target.</p><p>The study enrolled 120 patients presenting with chest pain in emergency departments across two clinical sites in Belgrade, Serbia. Participants were evaluated using both a standard 12-lead ECG and the HeartBeam System, with physician assessments compared against an independently adjudicated clinical data-based reference standard.</p><p>Data analysis is underway, and the company plans to present full results at a cardiology conference in the coming months.</p><p>HeartBeam said findings from the pilot are http://www.streetinsider.com/Corporate+News/HeartBeam+finishes+heart+attack+pilot+study+enrollment+early/26709433.html Tue, 30 Jun 2026 07:01:29 -0400 BEAT HeartBeam finishes heart attack pilot study enrollment early http://www.streetinsider.com/FDA/HeartBeam+finishes+heart+attack+pilot+study+enrollment+early/26709433.html <p>HeartBeam, Inc. (NASDAQ: BEAT) announced it has completed patient enrollment in its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection, ahead of its previously stated third-quarter 2026 target.</p><p>The study enrolled 120 patients presenting with chest pain in emergency departments across two clinical sites in Belgrade, Serbia. Participants were evaluated using both a standard 12-lead ECG and the HeartBeam System, with physician assessments compared against an independently adjudicated clinical data-based reference standard.</p><p>Data analysis is underway, and the company plans to present full results at a cardiology conference in the coming months.</p><p>HeartBeam said findings from the pilot are http://www.streetinsider.com/FDA/HeartBeam+finishes+heart+attack+pilot+study+enrollment+early/26709433.html Tue, 30 Jun 2026 07:01:29 -0400 BEAT HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ASS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ASS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ASS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ASS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26709375.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ACS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ACS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Press+Releases/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ACS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html <ul class="bwlistdisc"><li><i>Accelerated enrollment completion in ALIGN-ACS study underscores HeartBeam’s execution on its key strategic priority of heart attack detection</i></li><li><i>Data analysis is underway, with full results anticipated for presentation at upcoming cardiology conference</i></li><li><i>Findings will inform the design of the planned U.S. pivotal study and support the FDA pathway</i></li><li><i>Future indication expansion could unlock a large addressable market of millions of patients at risk</i></li></ul> <p> SANTA CLARA, Calif.--(BUSINESS WIRE)--</p> <p class="bwalignl"><a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54562562&newsitemid=20260630151674&lan=en-US&anchor=HeartBeam%2C+Inc.&index=485&md5=0706c73370034d96259e409645ef4776" shape="rect"><b>HeartBeam, Inc.</b></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through powerful cardiac insights, today announced completion of patient enrollment in its ALIGN-ACS pilot study http://www.streetinsider.com/Business+Wire/HeartBeam+Completes+Enrollment+in+Heart+Attack+Detection+Pilot+Study+Ahead+of+Schedule/26719393.html Tue, 30 Jun 2026 07:00:00 -0400 BEAT O.52737737 Form DEFA14A HeartBeam, Inc. http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++HeartBeam%2C+Inc.++++++++++++++++++++++/26688774.html si-local-file:///var/storage/secattach/20260625/26688774.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++HeartBeam%2C+Inc.++++++++++++++++++++++/26688774.html Thu, 25 Jun 2026 08:30:00 -0400 BEAT O.52737737 Form DEFA14A HeartBeam, Inc. http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++HeartBeam%2C+Inc.++++++++++++++++++++++/26688774.html si-local-file:///var/storage/secattach/20260625/26688774.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++HeartBeam%2C+Inc.++++++++++++++++++++++/26688774.html Thu, 25 Jun 2026 08:30:00 -0400 BEAT O.52737737 Form 8-K HeartBeam, Inc. For: Jun 18 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HeartBeam%2C+Inc.+++++++++++For%3A+Jun+18/26686563.html si-local-file:///var/storage/secattach/20260624/26686563.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++HeartBeam%2C+Inc.+++++++++++For%3A+Jun+18/26686563.html Wed, 24 Jun 2026 17:29:00 -0400 BEAT O.52737737